![David Brister](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Brister
Président chez
Health IQ Ltd.
Profil
David Brister is currently the Chairman at Biocleave Ltd., Health IQ Ltd., and Veryant, Inc. He previously held positions as Chairman at Domantis Ltd., Aitua Ltd., Optimal Medicine Ltd., and OMass Therapeutics Ltd. He also served as Executive Chairman at Mabey Holdings Ltd. and as Chief Business Officer at Evotec SE.
Additionally, he has experience as a Director at AM-Pharma BV, Crysalin Ltd., Xention Ltd., and Etiologics Ltd. Mr. Brister was an Independent Non-Executive Director at Ixico Plc from 2015 to 2016 and a Non-Executive Director at Pulmagen Therapeutics (Synergy) Ltd. He started his career as an Investment Manager at MVM Partners LLP in 2005 and later worked as an Operating Partner at Oxford Capital Partners LLP.
Mr. Brister obtained his undergraduate degree from The University of Sheffield.
Postes actifs de David Brister
| Sociétés | Poste | Début |
|---|---|---|
Biocleave Ltd.
 Biocleave Ltd. BiotechnologyHealth Technology Develops and sells microbial technology for the production of renewable chemicals and biofuels | Président | - |
Veryant, Inc.
 Veryant, Inc. Packaged SoftwareTechnology Services Veryant, Inc. provides powerful COBOL and Java technology solutions to enable organizations to quickly and safely extend current applications to meet new business needs and demands. The private company is based in Westchester, IL. The company's portable, robust solutions translate into cost-effective, future-proof computing. Veryant's ISCOBOL Evolve enables organizations to retain current COBOL investments while simultaneously offering a path forward to take advantage of the openness, portability, and power of the Java platform without retraining staff or rewriting code. | Directeur/Membre du Conseil | - |
Health IQ Ltd.
 Health IQ Ltd. Miscellaneous Commercial ServicesCommercial Services Provides information technology consulting services | Président | - |
Anciens postes connus de David Brister
| Sociétés | Poste | Fin |
|---|---|---|
| IXICO PLC | Directeur/Membre du Conseil | 16/09/2016 |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Private Equity Investor | 13/10/2006 |
OMass Therapeutics Ltd.
 OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform | Président | - |
Mabey Holdings Ltd.
 Mabey Holdings Ltd. Metal FabricationProducer Manufacturing Provides steel fabrication services | Président | - |
| EVOTEC SE | Corporate Officer/Principal | - |
Formation de David Brister
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Health Technology |
Ixico Plc
 Ixico Plc Miscellaneous Commercial ServicesCommercial Services Operates as a medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics | Commercial Services |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Mabey Holdings Ltd.
Mabey Holdings Ltd. Metal FabricationProducer Manufacturing Provides steel fabrication services | Producer Manufacturing |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Finance |
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases | Commercial Services |
Etiologics Ltd.
 Etiologics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies for chronic respiratory disorders | Commercial Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Capital Partners LLP
 Oxford Capital Partners LLP Investment ManagersFinance Oxford Capital Partners invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital transactions. The firm makes co-investments and takes a seat on the board of directors. The firm makes follow-on investments. | Finance |
Biocleave Ltd.
Biocleave Ltd. BiotechnologyHealth Technology Develops and sells microbial technology for the production of renewable chemicals and biofuels | Health Technology |
Aitua Ltd.
 Aitua Ltd. Investment ManagersFinance Engaged in the commercialization of intellectual properties of companies in the field of life sciences | Finance |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Veryant, Inc.
Veryant, Inc. Packaged SoftwareTechnology Services Veryant, Inc. provides powerful COBOL and Java technology solutions to enable organizations to quickly and safely extend current applications to meet new business needs and demands. The private company is based in Westchester, IL. The company's portable, robust solutions translate into cost-effective, future-proof computing. Veryant's ISCOBOL Evolve enables organizations to retain current COBOL investments while simultaneously offering a path forward to take advantage of the openness, portability, and power of the Java platform without retraining staff or rewriting code. | Technology Services |
Crysalin Ltd.
 Crysalin Ltd. BiotechnologyHealth Technology Develops technology for protein structure determination | Health Technology |
Xention Ltd.
 Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
Optimal Medicine Ltd.
 Optimal Medicine Ltd. Packaged SoftwareTechnology Services Offers individualized clinical decision support software for mental health disorders | Technology Services |
Health IQ Ltd.
Health IQ Ltd. Miscellaneous Commercial ServicesCommercial Services Provides information technology consulting services | Commercial Services |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform | Commercial Services |
